Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma

Published:2012-01 Issue:1 Volume:65 Page:23-30
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Gao Jianjun,Inagaki Yoshinori,Song Peipei,Qu Xianjun,Kokudo Norihiro,Tang Wei

Publisher

Elsevier BV

Subject

Pharmacology

Reference80 articles.

1. International Agency for Research on Cancer. Cancer incidence and mortality worldwide in 2008 (globocan 2008). http://globocaniarcfr [accessed 21.07.2011].

2. American Cancer Society. Cancer facts and figs 2005. http://wwwcancerorg/docroot/home/indexasp [accessed 21.07.2011].

3. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian oncology summit 2009;Poon;Lancet Oncol,2009

4. Sarcomatous change of hepatocellular carcinoma in a patient undergoing living donor liver transplantation;Kaneko;Biosci Trends,2010

5. The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation;Song;Biosci Trends,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cinobufacini Inhibits Survival and Metastasis of Hepatocellular Carcinoma via c-Met Signaling Pathway;Chinese Journal of Integrative Medicine;2024-07-19

2. Albumin-Based Cyanine Crizotinib Conjugate Nanoparticles for NIR-II Imaging-Guided Synergistic Chemophototherapy;ACS Applied Materials & Interfaces;2023-07-07

3. Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling;International Journal of Molecular Sciences;2023-04-30

4. Cu-promoted synthesis of Indolo[2,3-b]quinoxaline-Mannich adducts via three-component reaction and their anti-proliferative evaluation on colorectal and ovarian cancer cells;Journal of Molecular Structure;2023-03

5. Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs;Frontiers in Pharmacology;2022-06-07